Skip to content

Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke

Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02856035
Enrollment
4
Registered
2016-08-04
Start date
2017-01-01
Completion date
2018-09-28
Last updated
2020-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

chronic stroke, functional MRI, functional NIRS, motor learning, FES, upper extremity, neural feedback, arm/hand functional training

Brief summary

Stroke (795,000/year in the US and 30 million existing stroke survivors in the world) damages brain neural structures that control coordinated upper limb movement. To most effectively target the brain damage, interventions should be directed so as to restore brain control serving coordination of peripheral neuromuscular function. Currently, there is a lack of a transformative intervention strategy, and only limited efficacy is seen in response to neural rehabilitation that is only peripherally-directed (limbs e.g.) or only directed at the brain. This study will employ a novel neural feedback approach with a closed-loop, real-time paradigm to engage and retrain existing brain function after stroke. Real-time functional magnetic resonance imaging (rtfMIR) provides neural feedback with the advantage of precisely identifying the location of brain activity for multiple cognitive and emotional tasks. However, the rtfMRI is costly and precludes motor learning that requires sitting and engaging the upper limb in complex motor tasks during imaging acquisition. In contrast, real-time functional near-infrared spectroscopy (rtfNIRS), although not as spatially precise as rtfMRI, offers a low-cost, portable solution to provide brain neural feedback during motor learning. This proposal will utilize both technologies in a hybrid, sequential motor learning protocol. Moreover, the study protocol will also simultaneously involve both central effective signals (through neural feedback) and peripheral affective signals by employing neutrally-triggered functional electrical stimulation (FES)-assisted coordination practice, which produces peripherally-induced affective signals from muscle and joint receptors. This novel combination intervention protocol will engage the central nervous system, motor effective pathway training along with induction of affective signal production (FES-assisted practice), all of which will be implemented within the framework of evidence-based motor learning principles.

Detailed description

This study aims to develop and test an innovative protocol for recovery of wrist extension after stroke, using a combination of rtfMRI, rtfNIRS, FES, and motor learning. Aim I. Test the innovative coordination training protocol of combination rtfMRI/rtfNIRS central neural feedback and peripherally-directed, neurally-triggered FES-assisted coordination practice implemented within a framework of motor learning principles. Hypothesis 1. Chronic stroke survivors will show significant improvement in upper limb function in response to the combined rtfMRI/rtfNIRS central neural feedback; peripherally-directed FES-assisted coordination practice of wrist and finger extension; and whole arm/hand motor learning (Primary measure: Pre-/post-treatment change score in Arm Motor Abilities Test - function domain (AMAT - F); secondary measure: Pre/post-treatment change score in Fugl-Meyer upper limb coordination.

Interventions

OTHERNeural feedback plus FES and motor training

We are not testing the feasibility of the imaging methods; that has been well established and is used clinically. We are testing the feasibility of using neural feedback clinical imaging methods in a neural feedback paradigm which involves sequential rtfMRI (phase I) and rtfNIRS (phase II) training; Neurally-triggered, peripherally-directed FES-assist practice of wrist and finger extension will be combined with rtfNIRS training in Phase II; up to 60 total sessions, including additional motor learning sessions without brain neural feedback will be provided in Phase III.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

feasibility testing

Eligibility

Sex/Gender
ALL
Age
21 Years to 88 Years
Healthy volunteers
Yes

Inclusion criteria

* Cognition sufficiently intact to give valid informed consent to participate.\* * Sufficient endurance to participate in rehabilitation sessions. * Ability to follow 2 stage commands. * Medically Stable * Age \> 21 years. * Impaired upper limb function as follows: impaired ability to flex and extend the wrist. * At least 5 degrees of wrist flexion and extension of the wrist. * Passive ROM of wrist extension of at least 20 degrees. * At least 6 months post stroke.

Exclusion criteria

* Metal implants, pacemaker, claustrophobia, inability to operate the MRI patient call button or any other contraindications for MRI. * Acute or progressive cardiac (including cardiac arrhythmias), renal, respiratory, neurological disorders or malignancy. * Active psychiatric diagnosis or psychological condition, or active drug/alcohol abuse. * Lower motor neuron damage or radiculopathy. * More than one stroke. * Pregnancy (discontinued from the study, if a woman becomes pregnant). \* The combined scores for the Aid to Capacity Evaluation (ACE) and Mini-Mental Status Examination (MMSE) as follows: * MMSE 24-30 + the ACE score that states 'definitely capable' * MMSE 17 - 23 + the ACE score that states 'probably capable'

Design outcomes

Primary

MeasureTime frameDescription
Arm Motor Abilities Test Functional Domain (AMAT - F)change score from baseline to post-treatment; approximately 3 months.AMAT-F is a measure of 13 complex, coordinated tasks used in everyday living: functional normality of movement during the 13 tasks. Minimum clinically important difference (MCID) is 0.44 change score. AMAT-F : Arm Motor Abilities Test, functional domain. minimum = 0 points. maximum = 5 points. 5 points is normal function.

Secondary

MeasureTime frameDescription
Change Score From Baseline to Post Treatment for the Fugl Meyer Coordination Scalefrom baseline to post-treatment, approximately 3 monthsFM: Fugl-Meyer Coordination Scale: arm/hand coordination of isolated joint movement. The minimum clinically important difference (MCID) is 4.25 points. FM: 0 points, no movement; 66 points, normal coordination throughout the upper limb.

Countries

United States

Participant flow

Participants by arm

ArmCount
Arm/Group
4 Stroke survivors \> 6 months post stroke and moderately/severely impaired in upper limb coordination and function.
4
Total4

Baseline characteristics

CharacteristicArm/Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
AMAT-F1.5 points
STANDARD_DEVIATION 0.24
Race and Ethnicity Not Collected— Participants
Race/Ethnicity, Customized
African American
1 Participants
Race/Ethnicity, Customized
Asian
1 Participants
Race/Ethnicity, Customized
Caucasian
1 Participants
Race/Ethnicity, Customized
Hispanic
1 Participants
Region of Enrollment
United States
4 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 4
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

Arm Motor Abilities Test Functional Domain (AMAT - F)

AMAT-F is a measure of 13 complex, coordinated tasks used in everyday living: functional normality of movement during the 13 tasks. Minimum clinically important difference (MCID) is 0.44 change score. AMAT-F : Arm Motor Abilities Test, functional domain. minimum = 0 points. maximum = 5 points. 5 points is normal function.

Time frame: change score from baseline to post-treatment; approximately 3 months.

Population: severely impaired chronic stroke survivors

ArmMeasureValue (MEAN)Dispersion
Stroke GroupArm Motor Abilities Test Functional Domain (AMAT - F).54 units on a scaleStandard Error 0.1
Secondary

Change Score From Baseline to Post Treatment for the Fugl Meyer Coordination Scale

FM: Fugl-Meyer Coordination Scale: arm/hand coordination of isolated joint movement. The minimum clinically important difference (MCID) is 4.25 points. FM: 0 points, no movement; 66 points, normal coordination throughout the upper limb.

Time frame: from baseline to post-treatment, approximately 3 months

Population: severely impaired chronic stroke survivors

ArmMeasureValue (MEAN)Dispersion
Stroke GroupChange Score From Baseline to Post Treatment for the Fugl Meyer Coordination Scale10.05 units on a scaleStandard Error 3.38

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026